Sandoz will oversee commercialization of the product across the European Union (excluding Germany), Switzerland, Norway, ...

AAVB-039 is the company’s gene therapy program for Stargardt disease secondary to biallelic mutation in ABCA4.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Neurotech Pharmaceuticals announced the first commercial manufacturing, shipment, and surgical procedure of ENCELTO, the ...

PA5108 is a rod-shaped, biodegradable micro implant designed to significantly reduce IOP in patients with primary open-angle ...

AI plays a crucial role in the segmentation of diagnostic imaging, another area where precision is paramount. This platform ...

New research reveals that increased physical activity significantly slows visual field loss in glaucoma patients, ...

Ocular salvage and preservation of vision are essentially dependent on early diagnosis, and several studies have been ...

Obesity is a worldwide problem that is increasing. It also is associated with ocular problems. A recent study found that in ...

In a press release, the National Institute for Health and Care Excellence announced the first-ever approval for a ...

New findings confirm TearCare's long-term effectiveness for dry eye disease, showing significant patient improvements with ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.